loadpatents
Patent applications and USPTO patent grants for Lipella Pharmaceuticals Inc..The latest application filed is for "delivery of agents using metastable liposomes".
Patent | Date |
---|---|
Delivery of agents using metastable liposomes Grant 11,357,725 - Kaufman , et al. June 14, 2 | 2022-06-14 |
Delivery Of Agents Using Metastable Liposomes App 20200261364 - Kaufman; Jonathan H. ;   et al. | 2020-08-20 |
Delivery of agents using metastable liposomes Grant 10,639,278 - Kaufman , et al. | 2020-05-05 |
Systems And Methods Of Detecting Interstitial Cystitis App 20190094323 - KAUFMAN; Jonathan ;   et al. | 2019-03-28 |
Systems And Methods Of Detecting Interstitial Cystitis App 20170189564 - Kaufman; Jonathan ;   et al. | 2017-07-06 |
Delivery Of Agents Using Metastable Liposomes App 20160263031 - Kaufmann; Jonathan H. ;   et al. | 2016-09-15 |
Systems And Methods Of Detecting Interstitial Cystitis App 20160136306 - Kaufman; Jonathan ;   et al. | 2016-05-19 |
Systems and Methods to Image Intercellular and Intercompartmental Defects with Magnetic Resonance Imaging (MRI) App 20160045623 - KAUFMAN; Jonathan ;   et al. | 2016-02-18 |
Methods and Compositions for Treating Gastric Disorders App 20150037402 - Chancellor; Michael B. ;   et al. | 2015-02-05 |
Compositions And Methods For Treating Underactive Bladder App 20150030667 - KAUFMAN; Jonathan ;   et al. | 2015-01-29 |
Methods And Compositions For Treating Gastric Disorders App 20130071466 - Chancellor; Michael B. ;   et al. | 2013-03-21 |
Methods And Compositions For Treating Rhinitis App 20120263781 - Chancellor; Michael B. ;   et al. | 2012-10-18 |
Method Of Treatment For Bladder Dysfunction App 20120093920 - Chancellor; Michael B. ;   et al. | 2012-04-19 |
Instillation Of Liposomal Formulation Of Sirna And Antisense Oligonucleotides App 20110274745 - Chancellor; Michael B. ;   et al. | 2011-11-10 |
Method Of Treatment For Bladder Dysfunction App 20100104631 - Chancellor; Michael B. ;   et al. | 2010-04-29 |
NCAGE Code | 480R9 | LIPELLA PHARMACEUTICALS INC. |
CAGE Code | 480R9 | LIPELLA PHARMACEUTICALS INC. |
S.A.M. Registration | 480R9 [187190850] | LIPELLA PHARMACEUTICALS INC. |
SEC | 0001347242 | LIPELLA PHARMACEUTICALS INC of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.